Distinct steps in DNA fragmentation pathway during camptothecin-induced apoptosis involved caspase-, benzyloxycarbonyl- and N-tosyl-L-phenylalanylchloromethyl ketone-sensitive activities
- PMID: 9679972
Distinct steps in DNA fragmentation pathway during camptothecin-induced apoptosis involved caspase-, benzyloxycarbonyl- and N-tosyl-L-phenylalanylchloromethyl ketone-sensitive activities
Abstract
Monocytic-like leukemia U-937 cells rapidly undergo morphological changes and DNA fragmentation that is typical of apoptosis following treatment with DNA topoisomerase I inhibitor [20-S-camptothecin lactone (CPT)]. The tripeptide derivative benzyloxycarbonyl-Val-Ala-Asp(OMe)fluoromethyl ketone blocks Asp-Glu-Val-Asp-ase (DEVDase) activity and prevents the occurrence of high molecular weight and oligonucleosome-sized DNA fragments associated with apoptosis in CPT-treated cells. In contrast, N-tosyl-L-phenylalanylchloromethyl ketone (TPCK) does not prevent DEVDase activity and high molecular weight DNA fragmentation but completely abrogates the appearance of oligonucleosome-sized DNA fragmentation. These results suggest that caspase 3-like activities are involved with high molecular weight DNA fragmentation pathway, whereas TPCK-sensitive activities are involved in oligonucleosome-sized DNA fragmentation pathway in CPT-treated cells. Electron micrographs reveal that caspase inhibition by benzyloxycarbonyl-Val-Ala-Asp(OMe)fluoromethyl ketone also abrogates the typical morphological changes associated with apoptosis, whereas TPCK does not delay these morphological changes that are typical of apoptosis. Caspase inhibition slows passage of the cells through G2 and causes a transient accumulation of these cells at the G0/G1 phase of the cell cycle following CPT treatment. In a cell-free system, when purified nuclei are incubated with apoptotic cytosolic extracts obtained from CPT-treated U-937 cells, TPCK causes a similar effect in abrogating the oligonucleosome-sized DNA fragmentation but does not affect DEVDase activity. Addition of either benzyloxycarbonyl-Val-Ala-Asp-free carboxyl group or acetyl-Asp-Glu-Val-Asp-aldehyde completely inhibits DEVDase activity in these extracts. However, acetyl-Asp-Glu-Val-Asp-aldehyde does not affect the occurrence of oligonucleosome-sized DNA fragmentation in the cell-free system, whereas the benzyloxycarbonyl derivatives benzyloxycarbonyl-Val-Ala-Asp-free carboxyl group, benzyloxycarbonyl-Val-Ala-free hydroxyl group, benzyloxycarbonyl-Val-free hydroxyl group, and benzyloxycarbonyl hydrazide abolish it markedly. Taken together, these observations show the pivotal role of DEVDase activity in triggering the apoptotic process and high molecular weight DNA fragmentation, whereas TPCK- and benzyloxycarbonyl-sensitive activities are involved in the oligonucleosome-sized DNA fragmentation pathway induced by CPT.
Similar articles
-
The CrmA- and TPCK-sensitive pathways that trigger oligonucleosome-sized DNA fragmentation in camptothecin-induced apoptosis: relation to caspase activation and high molecular weight DNA fragmentation.Biochem Cell Biol. 1997;75(4):359-68. Biochem Cell Biol. 1997. PMID: 9493958
-
Bcl-xL modulates apoptosis induced by anticancer drugs and delays DEVDase and DNA fragmentation-promoting activities.Exp Cell Res. 1998 Apr 10;240(1):107-21. doi: 10.1006/excr.1998.4003. Exp Cell Res. 1998. PMID: 9570926
-
Caspase inhibition in camptothecin-treated U-937 cells is coupled with a shift from apoptosis to transient G1 arrest followed by necrotic cell death.Cancer Res. 1999 Aug 1;59(15):3565-9. Cancer Res. 1999. PMID: 10446962
-
The Bcl-xL and Bax-alpha control points: modulation of apoptosis induced by cancer chemotherapy and relation to TPCK-sensitive protease and caspase activation.Biochem Cell Biol. 1997;75(4):301-14. Biochem Cell Biol. 1997. PMID: 9493953 Review.
-
[The mechanism of apoptosis induced by anticancer agents in human leukemia cells].Nihon Rinsho. 1996 Jul;54(7):1822-7. Nihon Rinsho. 1996. PMID: 8741673 Review. Japanese.
Cited by
-
Imidazole metalloporphyrins as photosensitizers for photodynamic therapy: role of molecular charge, central metal and hydroxyl radical production.Cancer Lett. 2009 Sep 8;282(1):63-76. doi: 10.1016/j.canlet.2009.02.054. Epub 2009 Apr 5. Cancer Lett. 2009. PMID: 19346065 Free PMC article.
-
Revisiting the BRCA-pathway through the lens of replication gap suppression: "Gaps determine therapy response in BRCA mutant cancer".DNA Repair (Amst). 2021 Nov;107:103209. doi: 10.1016/j.dnarep.2021.103209. Epub 2021 Aug 13. DNA Repair (Amst). 2021. PMID: 34419699 Free PMC article. Review.
-
Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism.Free Radic Biol Med. 2007 Sep 1;43(5):711-9. doi: 10.1016/j.freeradbiomed.2007.05.005. Epub 2007 May 10. Free Radic Biol Med. 2007. PMID: 17664135 Free PMC article.
-
Proteomic analysis of enriched lysosomes at early phase of camptothecin-induced apoptosis in human U-937 cells.J Proteomics. 2009 Aug 20;72(6):960-73. doi: 10.1016/j.jprot.2009.04.003. Epub 2009 Apr 23. J Proteomics. 2009. PMID: 19393779 Free PMC article.
-
Protein kinase C-δ isoform mediates lysosome labilization in DNA damage-induced apoptosis.Int J Oncol. 2011 Feb;38(2):313-24. doi: 10.3892/ijo.2010.881. Epub 2010 Dec 20. Int J Oncol. 2011. PMID: 21174057 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials